OAS1 and prostate adenocarcinoma: In addition, silence of OAS1 significantly enhanced cisplatin-induced apoptosis both in LUAD cells and PRAD cells (Figure 9D and Supplementary Figure 1D), but impaired cell migration (Figure 9E and Supplementary Figure 1E).